Does contrast enhancement on CT suggest tumor response for chemotherapy in small cell carcinoma of the lung?

Journal of Computer Assisted Tomography

Volumn 26, Issue 5, 2002, Pages 797-800

  Choi, Jung Bin ^a   Park, Choong Ki ^a   Woo Park, Dong ^a   Kim, Yongsoo ^a   Kim, Young Sun ^a   Choi, Yo Won ^b   Jeon, Seok Chol ^b  

^a Hanyang University Guri Hospital   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

Cancer; Chemotherapy; Computed tomography (CT); Lung

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; CYTOLOGY; REGRESSION ANALYSIS;

% REDUCTIONS; CANCER; CELL CARCINOMA; CHEMOTHERAPY RESPONSE; COMPUTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HOUNSFIELD UNITS; LUNG; REDUCTION RATIOS; SMALL CELLS;

TUMORS;

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IOPROMIDE; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG EFFICACY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MALE; MULTIPLE REGRESSION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RELAPSE;

EID: 0036761235     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200209000-00021     Document Type: Article

References (10)

1. Lassen U, Osterlind K, Hansen M, et al. Long-term survival in small-cell lung cancer: Posttreatment characteristics in patients surviving 5 to 18 years - An analysis of 1,714 consecutive patients. J Clin Oncol 1995;13:1215-20.
2. Wolf M, Holle R, Hans K, et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival. Br J Cancer 1991;63:986-92.
3. Rawson NS, Peto J. An overview of prognostic factors in small cell lung cancer: A report from the subcommittee for the management of lung cancer of the United Kingdom Coordinating Committee on Cancer Research. Br J Cancer 1990;61:597-604.
4. Yamashita K, Matsunobe S, Tsuda T, et al. Solitary pulmonary nodule: Preliminary study of evaluation with incremental dynamic CT. Radiology 1995;94:399-405.
5. Swenson SJ, Brown LR, Colby TV, et al. Lung nodule enhancement at CT: Prospective findings. Radiology 1996;201:447-55.
6. Tanaka N, Inoue F, Takeda I, et al. Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion. Gan To Kagaku Ryoho 1988;15:59-66.
7. Postmus PE, Smit EF. Small cell lung cancer: Is there a standard therapy? Oncology (Huntingt) 1998;12:25-30.
8. Chute JP, Kelley MJ, Venzon D, et al. Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer. Chest 1996;110:165-71.
9. Greco FA. Treatment options for patients with relapsed small cell lung cancer. Lung Cancer 1993;9:85-9.
10. Greco FA, Richardson RL, Snell JD, et al. Small cell lung cancer: Complete remission and improved survival. Am J Med 1979;66:625-30.